Navigating New CMS Skin Substitute Updates: Essential Policies for Wound Care Providers

Wound care providers are entering a new compliance landscape, which will impact 10.5 million Medicare beneficiaries in the U.S. with chronic wounds.

Starting on January 1, 2026, the Centers for Medicare and Medicaid Services (CMS) will implement new Local Coverage Determinations (LCD), which will affect the use of cellular and tissue-based products (CTPs), also known as skin substitute grafts, for the treatment of diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). These new policies limit reimbursement for CTPs to just 17 approved products for DFUs, with five of them also approved for VLUs.

The LCD lists more than 100 non-covered products. Using non-covered products or failing to meet documentation standards can lead to reimbursement denials, audits, and delayed or disrupted care for vulnerable patients.

“We’ve seen a marked increase in engagement from our clients as they look to prepare their teams for these CMS skin substitute updates — not just in understanding the new policies, but in implementing sustainable processes that ensure compliance,” said Rachael Garner, Business Development Manager at Relias. “What’s even more encouraging is the influx of new organizations reaching out proactively to strengthen their wound care programs ahead of these changes.”

Key CMS skin substitute policy updates

Wound care providers must adapt their product selection, treatment workflows, and documentation to remain compliant. Here are some of the key policy changes:

• Four weeks of standard care are required

Before CTPs can be applied, patients must receive at least four weeks of standard wound care (e.g., debridement, offloading, compression) without adequate healing.

• Limited product coverage

Only 17 skin substitute products are covered.

• Maximum number of applications

A maximum of eight applications per wound in a 16-week treatment episode is allowed.

• Mid-treatment assessment is required

Providers must demonstrate clinical improvement before the fifth application, or treatment must be reconsidered.

• Strict documentation requirements

Providers must keep detailed medical records to justify using skin substitutes, including documentation of previous treatment failures, wound measurement tracking, KX modifier usage, and proof of medical necessity.

Why the CMS skin substitute updates matter

These policy changes represent a significant shift in wound care reimbursement:

• More denials and audits can occur if the documentation is inadequate.
• Providers must optimize every CTP they use, which means fewer chances to provide optimal care and get it right in the maximum number of applications allowed.
• Providers must be familiar with new requirements to avoid the risk of noncompliance.

How to reduce risk

With reimbursement limited to a narrow set of products and documentation scrutiny increasing, providers must take proactive steps to stay compliant and reduce risk. Here’s how:

1. Educate all team members

Everyone involved with the wound care process — nurses, therapists, physicians, and coders — should be briefed on the CMS skin substitute updates. Even small knowledge gaps can lead to costly errors.

Use regular staff training sessions, internal alerts, and microlearning tools to remember the rules. Consider wound care certification programs or clinical competency assessments for wound evaluation and treatment staff.

2. Invest in clinical education tools

Consider using structured education platforms to support ongoing staff learning. For example, Relias’ Wound Care Education Institute provides accredited skin and wound care, diabetic wound care, and ostomy management courses to help clinicians prepare for their certification exam. The courses cover current standards of care to ensure that staff are current on the latest practices, allowing your organization to reduce the risk of readmission and increase reimbursements.

3. Standardize documentation protocols

One of the best defenses against reimbursement denials is consistency. Establish shared documentation templates, checklists, or EMR protocols to capture required elements at every visit, especially across settings.

Include prompts for:

• Wound measurements and photos
• Description of prior standard care attempts
• Rationale for skin substitute use
• Response to treatment over time

The new CMS rule marks a turning point in how wound care is delivered, documented, and reimbursed. You can protect your patients and your bottom line by staying informed, investing in team education, and creating consistent care protocols. Aligning clinical practice with regulatory expectations can help your team ensure compliance, reduce denials, and deliver better care.